Anat Ben-Shlomo, MD
Tel Aviv University
Biography & Research Background
Anat Ben-Shlomo, MD, is an endocrinologist and researcher at Cedars-Sinai Medical Center (Los Angeles, California) and a member of the Melmed Research Lab, one of the world's preeminent pituitary research groups. She earned her medical degree from Tel Aviv University and specializes in the study of genomic changes underlying the development and progression of pituitary tumors, particularly growth hormone-secreting somatotroph adenomas that lead to acromegaly. Her landmark 2020 study in The Journal of Clinical Investigation demonstrated that intense cAMP stimulation by CJC-1295 in mouse pituitary cells induced DNA damage, as measured by H2AX phosphorylation and comet assays. This work revealed a critical link between GHRH receptor-mediated secretory activity and cellular stress in somatotrophs, showing that somatic copy number alterations (SCNAs) rather than genetic mutations are hallmarks of these tumors. Her key publication is "DNA damage and growth hormone hypersecretion in pituitary somatotroph adenomas" (2020, The Journal of Clinical Investigation). Anat Ben-Shlomo is being referenced as one of the leading scientists involved in CJC-1295 (no DAC) research. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure US Peptide and this doctor.
External Profiles
Authored Research Profiles (1)
Anat Ben-Shlomo, MD is referenced as a leading researcher in the following peptide research profiles on Pure U.S. Peptides:
Anat Ben-Shlomo, MD is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure U.S. Peptides and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.